Understanding how certain proteins affect lung injury caused by bacterial infections
Calpain/talin/MLCP axis in pulmonary endothelial barrier regulation
This study is looking at how certain bacteria can harm the lungs and cause acute lung injury, focusing on a specific enzyme that might help us find new ways to treat this condition and improve recovery for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-10911249 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms behind acute lung injury (ALI), particularly how bacterial toxins from E. coli and Streptococcus pneumoniae disrupt the lung's endothelial barrier. The study focuses on the role of calpain, a specific enzyme, and its interaction with proteins like talin and myosin light chain phosphatase (MLCP) in this process. By examining how these proteins are activated and how they contribute to lung injury, the research aims to identify potential therapeutic targets to prevent or mitigate ALI. Patients may benefit from insights gained into new treatments that could enhance lung function and recovery.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients experiencing acute lung injury or acute respiratory distress syndrome, particularly those with bacterial infections.
Not a fit: Patients with chronic lung conditions unrelated to acute bacterial infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve recovery from acute lung injuries caused by bacterial infections.
How similar studies have performed: Other research has shown promising results in targeting similar molecular pathways to improve outcomes in acute lung injury, suggesting that this approach may be effective.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Verin, Alexander D — Augusta University
- Study coordinator: Verin, Alexander D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.